1. Home
  2. FEAM vs CLNN Comparison

FEAM vs CLNN Comparison

Compare FEAM & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 5E Advanced Materials Inc.

FEAM

5E Advanced Materials Inc.

HOLD

Current Price

$1.24

Market Cap

81.4M

Sector

Industrials

ML Signal

HOLD

Logo Clene Inc.

CLNN

Clene Inc.

HOLD

Current Price

$4.94

Market Cap

69.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEAM
CLNN
Founded
2016
2012
Country
United States
United States
Employees
35
76
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.4M
69.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FEAM
CLNN
Price
$1.24
$4.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$6.38
$32.67
AVG Volume (30 Days)
226.7K
72.1K
Earning Date
05-14-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$12.20
Revenue Next Year
N/A
$20,465.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.25
$2.28
52 Week High
$7.50
$13.50

Technical Indicators

Market Signals
Indicator
FEAM
CLNN
Relative Strength Index (RSI) 26.37 45.53
Support Level N/A $3.54
Resistance Level $2.16 $6.83
Average True Range (ATR) 0.16 0.63
MACD -0.02 -0.12
Stochastic Oscillator 4.71 21.66

Price Performance

Historical Comparison
FEAM
CLNN

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: